Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.97
+0.15 (0.44%)
At close: Feb 11, 2026, 4:00 PM EST
32.93
-0.04 (-0.11%)
After-hours: Feb 11, 2026, 4:10 PM EST
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.66 billion as of February 11, 2026. Its market cap has increased by 3.67% in one year.
Market Cap
1.66B
Enterprise Value
1.21B
1-Year Change
3.67%
Ranking
Category
Stock Price
$32.97
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.66B, a decrease of -7.35%. That is a compound annual growth rate of -1.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.66B | -5.13% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 1.72B |
| Nurix Therapeutics | 1.70B |
| Zymeworks | 1.70B |
| Enliven Therapeutics | 1.70B |
| Corvus Pharmaceuticals | 1.68B |
| Tyra Biosciences | 1.66B |
| Celldex Therapeutics | 1.66B |
| Biohaven | 1.65B |